36 research outputs found
Differentiating Glaucomatous from Non-Glaucomatous Optic Nerve Cupping by Optical Coherence Tomography
Diagnostic Algorithm for Approaching Patients with Suspected Giant Cell Arteritis (P2. 278)
Pellegrini et al-"Reply to: Paracentral Acute Middle Maculopathy as a Manifestation of Giant Cell Arteritis": Response
Diagnostic algorithm for approaching patients with suspected temporal arteritis (P2.278)
Magnetic Resonance Imaging Abnormalities of the Optic Nerve Sheath and Intracranial Internal Carotid Artery in Giant Cell Arteritis
Background: Giant cell arteritis (GCA) is an important diagnostic consideration in elderly patients with vision changes. Superficial temporal artery biopsy (TAB) has long been considered the gold standard diagnostic approach for GCA, but MRI has gained interest as an alternative diagnostic modality. Although most of the literature has focused on imaging abnormalities of branches of the external carotid artery, there have been a few reports of GCA-related inflammatory involvement of the orbit and internal carotid arteries (ICAs) on MRI
Mural Enhancement of the Intracranial Internal Carotid Artery in Giant Cell Arteritis
"While autopsy studies of patients with giant cell arteritis (GCA) have demonstrated inflammatory involvement of the internal carotid artery (ICA), radiologic signs of ICA inflammation have not been a prominent feature in the published literature. We present three patients with biopsy-proven GCA who demonstrated evidence of mural enhancement of the intracranial ICAs by magnetic resonance imaging (MRI).
Retinal atrophy in eyes with resolved papilledema detected by optical coherence tomography
To apply automated spectral domain optical coherence tomography (SD-OCT) segmentation to eyes with resolving papilledema.
Ninety-four patients with idiopathic intracranial hypertension seen at the Duke Eye Center neuro-ophthalmology clinic between November 2010 and October 2011 were reviewed. Excluded were eyes with papilledema with Frisén grade >2, other optic neuropathies or retinopathies, and those that did not have SD-OCT imaging. The remaining 43 patients were split into 2 groups: non-atrophic papilledema and atrophic papilledema. Automated SD-OCT segmentation was performed on patients with non-atrophic papilledema and age-matched controls for each of the 9 regions of the Early Treatment Diabetic Retinopathy Study map. Bonferroni correction was used for multiple comparisons. All SD-OCT scans were reviewed for retinal structural abnormalities.
Total macular thickness was significantly thinner within the fovea and inner macular ring in non-atrophic papilledema vs control eyes (266 vs 276 μm, P = 0.04; 333 vs 344 μm P < 0.01, n = 26 non-atrophic papilledema, 30 controls). SD-OCT demonstrated thinning within the fovea, inner macular ring, and outer macular ring of the outer plexiform layer plus nuclear layer in non-atrophic papilledema vs control (124 vs 131 μm, P < 0.01; 112 vs 118 μm, P = 0.03; 95 vs 100 μm, P = 0.03). Retinal structural changes were seen in 21/33 eyes with atrophic papilledema vs none of the eyes with non-atrophic papilledema or controls.
SD-OCT shows qualitative and quantitative changes in the macula of eyes with resolved papilledema